2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Acta Pharmaceutica Sinica B ACTA PHARM SIN B （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.0
107人评分
我要评分
声誉 8.5 影响力 7.5 速度 7.5 | |||||||||||||||||
| 期刊ISSN | 2211-3835 | 安装APP，查看期刊最新消息
| ||||||||||||||||
| E-ISSN | 2211-3843 | |||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：14.49 | |||||||||||||||||
| 2025-2026自引率 | 4.1%点击查看自引率趋势图 | |||||||||||||||||
| 五年IF （数据来源于网友提供） | 16.896数据由网友[byte8848]收集提供 | |||||||||||||||||
| h-index | 28 | |||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||
| 期刊简介 |
| |||||||||||||||||
| 期刊官方网站 | https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b
稿件规范性与完整性预检 开始检查>>
| |||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/apsb/default.aspx
稿件规范性与完整性预检 开始检查>>
| |||||||||||||||||
| 作者指南网址 | https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/publish/guide-for-authors
稿件规范性与完整性预检 开始检查>>
| |||||||||||||||||
| 该期刊中国学者近期发文 - New | Generative active learning guided discovery of a tobramycin and ciprofloxacin adjuvant against multidrug-resistant Pseudomonas aeruginosa infections Author: Zhao, Siyu; Tang, Jie; Du, Ziyang; Li, Yujie; Zhou, Yingbo; Liu, Wenqian; Wu, Xiao; Hu, Xibing; Long, Xin; Lian, Dengchao; Xie, Jinglin; Xie, Tiantian; Dai, Shuo; He, Daxi; Su, Jiahui; Zhu, Youfeng; Chang, Yiqun; Zheng, Junxia; Liu, Jun; Sun, Pinghua Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2444-2473. DOI: 10.1016/j.apsb.2026.02.002 Fluorescence bioimaging of drug nanocarriers based on Fo¨rster resonance energy transfer, aggregation-induced emission and aggregation-caused quenching Author: Zhang, Runtong; He, Haisheng; Lu, Yi; Raza, Aun; Wu, Wei Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 1991-2028. DOI: 10.1016/j.apsb.2025.10.023 Isoalantolactone induces AML pyroptosis and potentiates α-PD-1 efficacy by targeting selenoprotein TXNRD1 Author: Yu, Xiaoxuan; Zhou, Yanyu; Sun, Shibo; Tang, Lu; Zhang, Wan; Xu, Jianqiang; Liu, Wukun Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2317-2331. DOI: 10.1016/j.apsb.2025.12.040 Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects Author: Yu, Li; Zhang, He; Shi, Chengge; Zhou, Qiang; Li, Jiayu; Lu, Bin; Lu, Hongyang; Jin, Ting; Zhu, Yinci; Zuo, Tianci; Xu, Mengzhu; Su, Mingli; Zhang, Yanmei; Shubhra, Quazi T. H.; Hu, Xiaowen; Deng, Hui; Cai, Xiaojun Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2527-2552. DOI: 10.1016/j.apsb.2026.01.031 | |||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Acta Pharmaceutica Sinica B的语言要求，还能让Acta Pharmaceutica Sinica B编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Acta Pharmaceutica Sinica B编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（2篇） 论文致谢 。 提交文稿 | |||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ Full Length Articles and Reviews - USD2600; Short Articles - USD2000; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：pharmaceutical science、traditional chinese medicine、pharmaceutics、pharmaceutical chemistry、pharmacokinetics 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||
| 通讯方式 | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES, C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, PEOPLES R CHINA, 10005 | |||||||||||||||||
| 出版商 | Elsevier BV | |||||||||||||||||
| 涉及的研究方向 | Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics | |||||||||||||||||
| 出版国家或地区 | CHINA MAINLAND | |||||||||||||||||
| 出版语言 | English | |||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||
| 出版年份 | 2011 | |||||||||||||||||
| 年文章数 | 345点击查看年文章数趋势图 | |||||||||||||||||
| Gold OA文章占比 | 99.37% | |||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 79.71% | |||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||
  | ||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D | |||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Submission to first decision: 8 days; Review time: 36 days; Submission to Accept: 134 days; Acceptance to publication: 7 days; 网友分享经验： 19 Weeks | |||||||||||||||||
| 平均录用比例 | 网友分享经验： 来源Elsevier官网： 9% | |||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ Full Length Articles and Reviews - USD2600; Short Articles - USD2000; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Acta Pharmaceutica Sinica B顺利发表。
快看看作者怎么说吧：服务好评（2篇） 论文致谢 。 提交文稿 | |||||||||||||||||
| 编辑信息 |
Editor-in-Chief Jian-Dong Jiang Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Materia Medica, Beijing, China Co-Editor-in-Chief Rui Wang China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China Associate Editors-in-Chief Xin-Xin Ding The University of Arizona, Tucson, Arizona, United States of America Shi-lin Chen China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China Wen-Xing Ding University of Kansas Medical Center, Kansas City, Kansas, United States of America De-An Guo China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Beijing, China Hongmin Li The University of Arizona College of Medicine Phoenix, Phoenix, Arizona, United States of America Rong-Guang Shao Chinese Academy of Medical Sciences Institute of Medicinal Biotechnology and Peking Union Medical College, Beijing, China Jian-Gong Shi China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica and Peking Union Medical College, Beijing, China Duxin Sun University of Michigan College of Pharmacy, Ann Arbor, Michigan, United States Xiao-Liang Wang China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica and Peking Union Medical College, Beijing, China Wen Xie University of Pittsburgh, School of Pharmacy, Department of Pharmaceutical Sciences, Pittsburgh, Pennsylvania, United States of America Jian-Ping Ye Shanghai Institute of Diabetes, Shanghai, China Jianhua Zhang The University of Alabama at Birmingham, Birmingham, Alabama, United States of America Haining Zhu The University of Arizona College of Pharmacy, Tucson, Arizona, United States of America Qiang Zhang Peking University School of Pharmaceutical Sciences, Beijing, China | |||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||
|
| |
| 中国学者近期发表的论文 | |
| 1. | Generative active learning guided discovery of a tobramycin and ciprofloxacin adjuvant against multidrug-resistant Pseudomonas aeruginosa infections Author: Zhao, Siyu; Tang, Jie; Du, Ziyang; Li, Yujie; Zhou, Yingbo; Liu, Wenqian; Wu, Xiao; Hu, Xibing; Long, Xin; Lian, Dengchao; Xie, Jinglin; Xie, Tiantian; Dai, Shuo; He, Daxi; Su, Jiahui; Zhu, Youfeng; Chang, Yiqun; Zheng, Junxia; Liu, Jun; Sun, Pinghua Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2444-2473. DOI: 10.1016/j.apsb.2026.02.002 PubMed DOI |
| 2. | Fluorescence bioimaging of drug nanocarriers based on Fo¨rster resonance energy transfer, aggregation-induced emission and aggregation-caused quenching Author: Zhang, Runtong; He, Haisheng; Lu, Yi; Raza, Aun; Wu, Wei Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 1991-2028. DOI: 10.1016/j.apsb.2025.10.023 PubMed DOI |
| 3. | Isoalantolactone induces AML pyroptosis and potentiates α-PD-1 efficacy by targeting selenoprotein TXNRD1 Author: Yu, Xiaoxuan; Zhou, Yanyu; Sun, Shibo; Tang, Lu; Zhang, Wan; Xu, Jianqiang; Liu, Wukun Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2317-2331. DOI: 10.1016/j.apsb.2025.12.040 PubMed DOI |
| 4. | Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects Author: Yu, Li; Zhang, He; Shi, Chengge; Zhou, Qiang; Li, Jiayu; Lu, Bin; Lu, Hongyang; Jin, Ting; Zhu, Yinci; Zuo, Tianci; Xu, Mengzhu; Su, Mingli; Zhang, Yanmei; Shubhra, Quazi T. H.; Hu, Xiaowen; Deng, Hui; Cai, Xiaojun Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2527-2552. DOI: 10.1016/j.apsb.2026.01.031 PubMed DOI |
| 5. | From conceptual design to translational progress: Emerging advances in intelligent microneedles for biomedical applications Author: Yin, Yue; Zhao, Qiaoqiao; Wang, Zihan; Li, Zixuan; Liu, Hening; Eghbalitabar, Fatemeh; Shang, Jing; Tang, Lu; Wang, Wei Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 1804-1847. DOI: 10.1016/j.apsb.2026.01.021 PubMed DOI |
| 6. | Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution Author: Xu, Xin; Cui, Lili; Zhang, Yong; Gu, Jingkai Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 1943-1970. DOI: 10.1016/j.apsb.2025.11.023 PubMed DOI |
| 7. | Self-assembled nanoplatforms for cancer immunotherapy: Principles, progress and perspectives Author: Xu, Wenfei; Zhu, Shuxuan; Sun, Zhaogang; Ye, Jun; Chu, Hongqian Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2196-2231. DOI: 10.1016/j.apsb.2025.06.011 PubMed DOI |
| 8. | An oral immune enhancer with excellent biocompatibility for effectively strengthening body's immunity and treating cancer Author: Xie, Anqi; Feng, Lei; Shao, Yaping; Wan, Yiqun; Zhang, Ying; Liu, Zheyi; Ji, Haihua; Wan, Hao Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2474-2497. DOI: 10.1016/j.apsb.2026.01.041 PubMed DOI |
| 9. | Artificial intelligence for drug delivery: Yesterday, today and tomorrow Author: Wu, Yiyang; Wang, Nannan; Xiong, Ping; Wang, Ruifeng; Deng, Jiayin; Ouyang, Defang Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2068-2092. DOI: 10.1016/j.apsb.2025.09.022 PubMed DOI |
| 10. | SIM: Discovery of novel RNA-targeting argonautes by self-iterative learning from scarce data Author: Peng, Shuze; Huang, Feiming; Li, Nuolan; Vidaurre, Karl Luigi Loza; Chen, Luer; Yang, Yu; Hu, Jiaying; Kou, Yanyu; He, Wei; Wang, Shiwei; Shi, Lei; Tao, Kehao; Sun, Bo; Song, Xiaoxuan; Yang, Hao; Zhang, Hainan; Yang, Lin; Deng, Zixin; Han, Yanqiang; Feng, Yan; Liu, Qian; Li, Jinjin Journal: ACTA PHARMACEUTICA SINICA B. 2026; Vol. 16, Issue 4, pp. 2282-2298. DOI: 10.1016/j.apsb.2026.01.009 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共288条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
